Cargando...

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio, Paolo Antonio Ascierto, Maria Vincenza Carriero
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Assuntos:
Acceso en liña:https://www.mdpi.com/1422-0067/21/12/4544
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!